Nationwide Fund Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-26,531
| Closed | -$314K | – | 1881 |
|
|
2017
Q3 | $314K | Hold |
26,531
| – | – | ﹤0.01% | 2419 |
|
|
2017
Q2 | $267K | Buy |
26,531
+5,167
| +24% | +$52K | ﹤0.01% | 2502 |
|
|
2017
Q1 | $249K | Sell |
21,364
-56,767
| -73% | -$662K | ﹤0.01% | 2487 |
|
|
2016
Q4 | $363K | Sell |
78,131
-27,718
| -26% | -$129K | ﹤0.01% | 2344 |
|
|
2016
Q3 | $819K | Sell |
105,849
-3,055
| -3% | -$23.6K | ﹤0.01% | 1905 |
|
|
2016
Q2 | $660K | Buy |
108,904
+86,573
| +388% | +$525K | ﹤0.01% | 1986 |
|
|
2016
Q1 | $207K | Sell |
22,331
-1,170
| -5% | -$10.8K | ﹤0.01% | 2525 |
|
|
2015
Q4 | $280K | Buy |
23,501
+613
| +3% | +$7.3K | ﹤0.01% | 2390 |
|
|
2015
Q3 | $231K | Hold |
22,888
| – | – | ﹤0.01% | 2490 |
|
|
2015
Q2 | $380K | Buy |
22,888
+2,543
| +12% | +$42.2K | ﹤0.01% | 2403 |
|
|
2015
Q1 | $315K | Sell |
20,345
-380
| -2% | -$5.88K | ﹤0.01% | 2472 |
|
|
2014
Q4 | $328K | Buy |
20,725
+2,708
| +15% | +$42.9K | ﹤0.01% | 2413 |
|
|
2014
Q3 | $192K | Buy |
18,017
+57
| +0.3% | +$607 | ﹤0.01% | 2710 |
|
|
2014
Q2 | $169K | Buy |
17,960
+4,918
| +38% | +$46.3K | ﹤0.01% | 2829 |
|
|
2014
Q1 | $90K | Buy |
13,042
+822
| +7% | +$5.67K | ﹤0.01% | 2771 |
|
|
2013
Q4 | $48K | Hold |
12,220
| – | – | ﹤0.01% | 3066 |
|
|
2013
Q3 | $62K | Buy |
12,220
+8,173
| +202% | +$41.5K | ﹤0.01% | 3027 |
|
|
2013
Q2 | $26K | Buy |
+4,047
| New | +$26K | ﹤0.01% | 3062 |
|